1. Bergmark, E., 1992, Hemoglobin Dosimetry and Comparative Toxicity of Acrylamide and its Metabolite Glycidamide, Doctoral Thesis, Dept. of Radiobiology, Stockholm University, Sweden.
2. Bergmark, E., 1997, Hemoglobin adducts of acrylamide and acetonitrile in laboratory workers, smokers, and nonsmokers, Chem. Res. Toxicol.
10: 78–84.
3. Bergmark, E., Calleman, C.J., He, F., and Costa, L.G., 1993, Determination of hemoglobin adducts in humans occupationally exposed to acrylamide, Toxicol. Appl. Pharmacol.
120: 45–54.
4. Calleman, C.-J., 1996, The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk, Drug Metab. Rev.
28: 527–590.
5. Calleman, C.J., Ehrenberg, L., Jansson, B., Osterman-Golkar, S., Segerbäck, D., Svensson, K., and Wachtmeister, C.A., 1978, Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide, J. Environ. Pathol. Toxicol.
2: 427–442.